Sopharma AD-Sofia (WAR:SPH) Interest Expense : zł-26 Mil (TTM As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sopharma AD-Sofia's interest expense for the three months ended in Jun. 2024 was zł -7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was zł-26 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sopharma AD-Sofia's Operating Income for the three months ended in Jun. 2024 was zł 36 Mil. Sopharma AD-Sofia's Interest Expense for the three months ended in Jun. 2024 was zł -7 Mil. Sopharma AD-Sofia's Interest Coverage for the quarter that ended in Jun. 2024 was 5.41. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sopharma AD-Sofia Interest Expense Historical Data

The historical data trend for Sopharma AD-Sofia's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Interest Expense Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-24.97

-27.04

-23.52

-13.12

-22.26

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Interest Expense	Get a 7-Day Free Trial															-5.01	-7.64	-5.54	-6.39	-6.71

Sopharma AD-Sofia Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-26 Mil.

Sopharma AD-Sofia (WAR:SPH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sopharma AD-Sofia's Interest Expense for the three months ended in Jun. 2024 was zł-7 Mil. Its Operating Income for the three months ended in Jun. 2024 was zł36 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was zł245 Mil.

Sopharma AD-Sofia's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2024 )	/	Interest Expense (Q: Jun. 2024 )
	=	-1	*	36.29	/	-6.712
	=	5.41

The higher the ratio, the stronger the company's financial strength is.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.